Growth Metrics

Quest Diagnostics (DGX) Depreciation & Amortization (CF) (2016 - 2026)

Quest Diagnostics' Depreciation & Amortization (CF) history spans 18 years, with the latest figure at $147.0 million for Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 5.0% to $147.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $577.0 million, a 11.61% increase, with the full-year FY2025 number at $570.0 million, up 15.62% from a year prior.
  • Depreciation & Amortization (CF) hit $147.0 million in Q1 2026 for Quest Diagnostics, up from $145.0 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for DGX hit a ceiling of $147.0 million in Q1 2026 and a floor of $106.0 million in Q1 2022.
  • Historically, Depreciation & Amortization (CF) has averaged $122.7 million across 5 years, with a median of $116.0 million in 2022.
  • Biggest five-year swings in Depreciation & Amortization (CF): fell 6.03% in 2023 and later increased 23.85% in 2024.
  • Tracing DGX's Depreciation & Amortization (CF) over 5 years: stood at $116.0 million in 2022, then decreased by 6.03% to $109.0 million in 2023, then rose by 23.85% to $135.0 million in 2024, then increased by 7.41% to $145.0 million in 2025, then grew by 1.38% to $147.0 million in 2026.
  • Business Quant data shows Depreciation & Amortization (CF) for DGX at $147.0 million in Q1 2026, $145.0 million in Q4 2025, and $142.0 million in Q3 2025.